Monte Rosa Therapeutics, Inc.
GLUE · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $512,936 | $290,393 | $359,400 | $950,264 |
| - Cash | $224,254 | $128,101 | $54,912 | $346,071 |
| + Debt | $42,715 | $46,039 | $47,001 | $0 |
| Enterprise Value | $331,397 | $208,331 | $351,489 | $604,193 |
| Revenue | $75,622 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $67,501 | -$6,222 | $0 | $0 |
| % Margin | 89.3% | – | – | – |
| EBITDA | -$72,991 | -$137,089 | -$108,639 | -$70,750 |
| % Margin | -96.5% | – | – | – |
| Net Income | -$72,700 | -$135,352 | -$108,501 | -$73,958 |
| % Margin | -96.1% | – | – | – |
| EPS Diluted | -0.98 | -2.63 | -2.3 | -1.59 |
| % Growth | 62.7% | -14.3% | -44.7% | – |
| Operating Cash Flow | $41,996 | -$43,802 | -$92,466 | -$59,363 |
| Capital Expenditures | -$3,988 | -$19,041 | -$12,911 | -$9,732 |
| Free Cash Flow | $38,008 | -$62,843 | -$105,377 | -$69,095 |